Megan is Avive’s FDA Strategist, and advises the company on its regulatory strategy and participates in all FDA interactions. Most notably, Megan was the former FDA Branch Chief of Cardiac EP Devices, where she led the Cardiac Electrophysiology and Monitoring Network. Specifically, she was responsible for ensuring coordinated regulation of pacemakers, defibrillators, EP devices, and cardiac monitoring systems at FDA.
Team Bios
Bio